EMEA-002266-PIP01-17
Key facts
| Active substance |
Recombinant human acid ceramidase (RVT-801)
|
| Therapeutic area |
Other
|
| Decision number |
P/0319/2018
|
| PIP number |
EMEA-002266-PIP01-17
|
| Pharmaceutical form(s) |
Solution for infusion
|
| Condition(s) / indication(s) |
Farber disease
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Aceragen Inc.
Tel. +15182583364 |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|